Works by Lublin, Fred

Results: 96
    1

    Relationship between sodium and diffusion MRI metrics in multiple sclerosis.

    Published in:
    Brain Communications, 2025, v. 7, n. 1, p. 1, doi. 10.1093/braincomms/fcae446
    By:
    • Cipriano, Emilio;
    • Boffa, Giacomo;
    • Graziano, Nicole;
    • Wigley, Claire;
    • Petracca, Maria;
    • Schiavi, Simona;
    • Mancardi, Giovanni Luigi;
    • Klineova, Sylvia;
    • Boada, Fernando;
    • Lublin, Fred;
    • Inglese, Matilde;
    • Fleysher, Lazar
    Publication type:
    Article
    2

    Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2021, v. 78, n. 5, p. 558, doi. 10.1001/jamaneurol.2021.0405
    By:
    • Kappos, Ludwig;
    • Fox, Robert J.;
    • Burcklen, Michel;
    • Freedman, Mark S.;
    • Havrdová, Eva K.;
    • Hennessy, Brian;
    • Hohlfeld, Reinhard;
    • Lublin, Fred;
    • Montalban, Xavier;
    • Pozzilli, Carlo;
    • Scherz, Tatiana;
    • D'Ambrosio, Daniele;
    • Linscheid, Philippe;
    • Vaclavkova, Andrea;
    • Pirozek-Lawniczek, Magdalena;
    • Kracker, Hilke;
    • Sprenger, Till
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Dissociable cognitive patterns related to depression and anxiety in multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1247, doi. 10.1177/1352458519860319
    By:
    • Leavitt, Victoria M;
    • Brandstadter, Rachel;
    • Fabian, Michelle;
    • Katz Sand, Ilana;
    • Klineova, Sylvia;
    • Krieger, Stephen;
    • Lewis, Christina;
    • Lublin, Fred;
    • Miller, Aaron;
    • Pelle, Gabrielle;
    • Buyukturkoglu, Korhan;
    • De Jager, Phillip L;
    • Li, Peipei;
    • Riley, Claire S;
    • Tsapanou, Angeliki;
    • Sumowski, James F
    Publication type:
    Article
    9
    10
    11
    12
    13

    The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.

    Published in:
    Multiple Sclerosis Journal, 2018, v. 24, n. 11, p. 1469, doi. 10.1177/1352458517723718
    By:
    • LaRocca, Nicholas G.;
    • Hudson, Lynn D.;
    • Rudick, Richard;
    • Amtmann, Dagmar;
    • Balcer, Laura;
    • Benedict, Ralph;
    • Bermel, Robert;
    • Chang, Ih;
    • Chiaravalloti, Nancy D.;
    • Chin, Peter;
    • Cohen, Jeffrey A.;
    • Cutter, Gary R.;
    • Davis, Mat D.;
    • DeLuca, John;
    • Feys, Peter;
    • Francis, Gordon;
    • Goldman, Myla D.;
    • Hartley, Emily;
    • Kapoor, Raj;
    • Lublin, Fred
    Publication type:
    Article
    14
    15
    16
    17
    18

    Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2011, v. 17, n. 8, p. 970, doi. 10.1177/1352458511399611
    By:
    • Phillips, J. Theodore;
    • Giovannoni, Gavin;
    • Lublin, Fred D.;
    • O’Connor, Paul W;
    • Polman, Chris H.;
    • Willoughby, Ernie;
    • Aschenbach, William;
    • Pace, Amy;
    • Hyde, Robert;
    • Munschauer, Frederick E.
    Publication type:
    Article
    19

    Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.

    Published in:
    Annals of Neurology, 2011, v. 69, n. 2, p. 292, doi. 10.1002/ana.22366
    By:
    • Polman, Chris H.;
    • Reingold, Stephen C.;
    • Banwell, Brenda;
    • Clanet, Michel;
    • Cohen, Jeffrey A.;
    • Filippi, Massimo;
    • Fujihara, Kazuo;
    • Havrdova, Eva;
    • Hutchinson, Michael;
    • Kappos, Ludwig;
    • Lublin, Fred D.;
    • Montalban, Xavier;
    • O'Connor, Paul;
    • Sandberg-Wollheim, Magnhild;
    • Thompson, Alan J.;
    • Waubant, Emmanuelle;
    • Weinshenker, Brian;
    • Wolinsky, Jerry S.
    Publication type:
    Article
    20

    Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.

    Published in:
    Annals of Neurology, 2010, v. 68, n. 3, p. 409, doi. 10.1002/ana.22083
    By:
    • Berger, Joseph R.;
    • Centonze, Diego;
    • Comi, Giancarlo;
    • Confavreux, Christian;
    • Cutter, Gary;
    • Giovannoni, Gavin;
    • Gold, Ralf;
    • Hartung, Hans-Peter;
    • Lublin, Fred;
    • Miravalle, Augusto;
    • Montalban, Xavier;
    • O'Connor, Paul;
    • Olsson, Tomas;
    • Polman, Chris H.;
    • Stuve, Olaf;
    • Wolinsky, Jerry S.;
    • Ziemssen, Tjalf
    Publication type:
    Article
    21

    Health-related quality of life in multiple sclerosis: effects of natalizumab.

    Published in:
    Annals of Neurology, 2007, v. 62, n. 4, p. 335, doi. 10.1002/ana.21163
    By:
    • Rudick, Richard A.;
    • Miller, Deborah;
    • Hass, Steve;
    • Hutchinson, Michael;
    • Calabresi, Peter A.;
    • Confavreux, Christian;
    • Galetta, Steven L.;
    • Giovannoni, Gavin;
    • Havrdova, Eva;
    • Kappos, Ludwig;
    • Lublin, Fred D.;
    • Miller, David H.;
    • O'Connor, Paul W.;
    • Phillips, J. Theodore;
    • Polman, Chris H.;
    • Radue, Ernst-Wilhelm;
    • Stuart, William H.;
    • Wajgt, Andrzej;
    • Weinstock-Guttman, Bianca;
    • Wynn, Daniel R.
    Publication type:
    Article
    22
    23

    Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

    Published in:
    2001
    By:
    • McDonald, W. Ian;
    • Compston, Alistair;
    • Edan, Gilles;
    • Goodkin, Donald;
    • Hartung, Hans-Peter;
    • Lublin, Fred D.;
    • McFarland, Henry F.;
    • Paty, Donald W.;
    • Polman, Chris H.;
    • Reingold, Stephen C.;
    • Sandberg-Wollheim, Magnhild;
    • Sibley, William;
    • Thompson, Alan;
    • Van Den Noort, Stanley;
    • Weinshenker, Brian Y.;
    • Wolinsky, Jerry S.;
    • McDonald, W I;
    • Compston, A;
    • Edan, G;
    • Goodkin, D
    Publication type:
    journal article
    24
    25
    26
    27

    Clinical outcomes assessment in multiple sclerosis.

    Published in:
    Annals of Neurology, 1996, v. 40, n. 3, p. 469, doi. 10.1002/ana.410400321
    By:
    • Rudick, Richard;
    • Fischer, Jill;
    • Antel, Jack;
    • Confavreux, Christian;
    • Cutter, Gary;
    • Ellison, George;
    • Lublin, Fred;
    • Miller, Aaron;
    • Petkau, John;
    • Rao, Stephen;
    • Reingold, Stephen;
    • Syndulko, Karl;
    • Thompson, Alan;
    • Wallenberg, Joy;
    • Weinshenker, Brain;
    • Willoughby, Ernest
    Publication type:
    Article
    28
    29

    Autoimmune inflammation of astrocyte transplants.

    Published in:
    Annals of Neurology, 1992, v. 31, n. 5, p. 519, doi. 10.1002/ana.410310510
    By:
    • Lublin, Fred D.;
    • Marini, Joseph C.;
    • Perreault, Marielle;
    • Olender, Christina;
    • D'Imperio, Concetta;
    • Joseph, Jeymohan;
    • Korngold, Robert;
    • Knobler, Robert L.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.

    Published in:
    Brain: A Journal of Neurology, 2014, v. 137, n. 8, p. 2271, doi. 10.1093/brain/awu139
    By:
    • Vidaurre, Oscar G.;
    • Haines, Jeffery D.;
    • Katz Sand, Ilana;
    • Adula, Kadidia P.;
    • Huynh, Jimmy L.;
    • McGraw, Corey A.;
    • Zhang, Fan;
    • Varghese, Merina;
    • Sotirchos, Elias;
    • Bhargava, Pavan;
    • Bandaru, Veera Venkata Ratnam;
    • Pasinetti, Giulio;
    • Zhang, Weijia;
    • Inglese, Matilde;
    • Calabresi, Peter A.;
    • Wu, Gang;
    • Miller, Aaron E.;
    • Haughey, Norman J.;
    • Lublin, Fred D.;
    • Casaccia, Patrizia
    Publication type:
    Article
    39

    Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

    Published in:
    Brain: A Journal of Neurology, 1999, v. 122, n. 5, p. 871, doi. 10.1093/brain/122.5.871
    By:
    • Cutter, Gary R.;
    • Baier, Monika L.;
    • Rudick, Richard A.;
    • Cookfair, Diane L.;
    • Fischer, Jill S.;
    • Petkau, John;
    • Syndulko, Karl;
    • Weinshenker, Brian G.;
    • Antel, Jack P.;
    • Confavreux, Christian;
    • Ellison, George W.;
    • Lublin, Fred;
    • Miller, Aaron E.;
    • Rao, Stephen M.;
    • Reingold, Stephen;
    • Thompson, Alan;
    • Willoughby, Ernest
    Publication type:
    Article
    40
    41
    42
    43

    The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

    Published in:
    Journal of Neurology, 2009, v. 256, n. 3, p. 405, doi. 10.1007/s00415-009-0093-1
    By:
    • Hutchinson, Michael;
    • Kappos, Ludwig;
    • Calabresi, Peter A.;
    • Confavreux, Christian;
    • Giovannoni, Gavin;
    • Galetta, Steven L.;
    • Havrdova, Eva;
    • Lublin, Fred D.;
    • Miller, David H.;
    • O'Connor, Paul W.;
    • Phillips, J. Theodore;
    • Polman, Chris H.;
    • Radue, Ernst-Wilhelm;
    • Rudick, Richard A.;
    • Stuart, William H.;
    • Wajgt, Andrzej;
    • Weinstock-Guttman, Bianca;
    • Wynn, Daniel R.;
    • Lynn, Frances;
    • Panzara, Michael A.
    Publication type:
    Article
    44
    45
    46

    Cerebellar volume as imaging outcome in progressive multiple sclerosis.

    Published in:
    PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176519
    By:
    • Inglese, Matilde;
    • Petracca, Maria;
    • Mormina, Enricomaria;
    • Achiron, Anat;
    • Straus-Farber, Rebecca;
    • Miron, Shmuel;
    • Fabian, Michelle;
    • Krieger, Stephen;
    • Miller, Aaron;
    • Lublin, Fred;
    • Sormani, Maria Pia
    Publication type:
    Article
    47

    Association of subacute motor neuronopathy with thymoma.

    Published in:
    1984
    By:
    • Stoll, David B.;
    • Lublin, Fred;
    • Brodovsky, Harvey;
    • Frederick Laucius, J.;
    • Patchefsky, Arthur;
    • Cooper, Harry;
    • Stoll, D B;
    • Lublin, F;
    • Brodovsky, H;
    • Laucius, J F;
    • Patchefsky, A;
    • Cooper, H
    Publication type:
    journal article
    48
    49
    50

    No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.

    Published in:
    Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 1, p. 1, doi. 10.1177/2055217318760642
    By:
    • Havrdová, Eva;
    • Arnold, Douglas L.;
    • Bar-Or, Amit;
    • Comi, Giancarlo;
    • Hartung, Hans-Peter;
    • Kappos, Ludwig;
    • Lublin, Fred;
    • Selmaj, Krzysztof;
    • Traboulsee, Anthony;
    • Belachew, Shibeshih;
    • Bennett, Iain;
    • Buffels, Regine;
    • Garren, Hideki;
    • Han, Jian;
    • Julian, Laura;
    • Napieralski, Julie;
    • Hauser, Stephen L.;
    • Giovannoni, Gavin
    Publication type:
    Article